Evidence map›Paper›PMID 33853963›Full record

ArticleJournal of virology2021

Cyclic AMP-Dependent Protein Kinase Exhibits Antagonistic Effects on the Replication Efficiency of Different Human Papillomavirus Types.

Elina Lototskaja, Olga Sahharov, Marko Piirsoo, Martin Kala, Mart Ustav, Alla Piirsoo

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elina Lototskaja *Institute of Technology, University of Tartu, Tartu, Estonia.
Olga Sahharov *Institute of Technology, University of Tartu, Tartu, Estonia.
Marko PiirsooInstitute of Technology, University of Tartu, Tartu, Estonia.
Martin KalaInstitute of Technology, University of Tartu, Tartu, Estonia.
Mart UstavInstitute of Technology, University of Tartu, Tartu, Estonia.
Alla PiirsooInstitute of Technology, University of Tartu, Tartu, Estonia.
University of Tartu · EE

Funding

EC | European Regional Development Fund (ERDF) 2014-2020.4.01.15-013Estonian Research Council IUT20-27Estonian Research Council PRG198
6 · The paper itself

Abstract

Several types of widespread human papillomaviruses (HPVs) may induce the transformation of infected cells, provoking the development of neoplasms. Two main genera of HPVs are classified as mucosatropic alphapapillomaviruses and cutaneotropic betapapillomaviruses (α- and β-HPVs, respectively), and they both include high-risk cancer-associated species. The absence of antiviral drugs has driven investigations into the details of the molecular mechanisms of the HPV life cycle. HPV replication depends on the viral helicase E1 and the transcription factor E2. Their biological activities are controlled by numerous cellular proteins, including protein kinases. Here, we report that ubiquitously expressed cyclic AMP-dependent protein kinase A (PKA) differentially regulates the replication of α-HPV11, α-HPV18, and β-HPV5. PKA stimulates the replication of both α-HPVs studied but has a more profound effect on the replication of high-risk α-HPV18. However, the replication of β-HPV5 is inhibited by activated PKA in human primary keratinocytes and U2OS cells. We show that the activation of PKA signaling by different pharmacological agents induces the rapid proteasomal degradation of the HPV5 E2 protein, which in turn leads to the downregulation of E2-dependent transcription. In contrast, PKA-stimulated induction of HPV18 replication is the result of the downregulation of the

Indexed as

Cell Line, TumorCyclic AMP-Dependent Protein Kinase Type IDNA HelicasesGenome, ViralHuman papillomavirus 18HumansOncogene Proteins, ViralPapillomavirus InfectionsTranscription FactorsVirus ReplicationCyclic AMP-Dependent Protein Kinase Type IDNA Helicasesoncogene protein E1, Human papillomavirus type 18oncogene protein E2, Human papillomavirus type 18Oncogene Proteins, ViralTranscription Factorshuman papillomavirusPKAviral replication

Identifiers

PMID33853963
PMCPMC8316020
OpenAlexW3156214665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.